Inventiv Health (VTIV) Inactive 10-Q2004 Q1 Quarterly report

Filed: 6 May 04, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: accelerated, activity, advertising, advice, applicable, array, behalf, Boehringer, build, check, Clinical, comply, concentration, conduct, counsel, delivery, diver, dividing, ensure, equipment, exposed, FASB, filer, ge, GlaxoSmithKline, hedging, hereof, Identification, incenti, Ingleheim, issuer, kind, leverage, mark, merit, ofsmall, par, past, practicable, professional, prominent, provisi, quoted, ran, reassigned, redit, registrant, regulation, risk, se, shorter, spectrum, transition, unfavorably, ve, voluntary, VPS, Washington, weighted, won

Removed: advance, aforementioned, AG, Alpharetta, aware, BMS, closed, commence, commercialization, communicate, comprising, conform, Connecticut, connection, consist, consistent, covered, deploy, determined, developed, disposal, effectively, efficient, effort, enhance, estimate, estimating, executing, explained, extent, February, final, focused, France, freely, Germany, highly, ii, iii, implementing, incidental, input, involved, involving, litigation, longer, manner, marketplace, November, office, operation, paid, partially, participation, permissible, phase, prescription, prevailing, prior, project, rapidly, reclassified, reconciliation, recruit, reduce, reduction, reliable, Reliant, repaid, repayment, requisite, restructuring, resulting, satisfied, scheduled, service, significantly, Similarly, single, size, slight, Standard, subjective, subsequently, supervision, threatened, traded, train, transaction, transferable, turnover, valuation, vesting, VHSM, VIS, volatility

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

VTIV similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Ventiv Health, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2004 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John R. Emery, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and to the best of my knowledge and belief, that:

(1) The Report fully complies with the requirements of section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 (16 U.S.C. 78m or 78o(d)); and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ JOHN R. EMERY

John R. Emery

Chief Financial Officer

May 6, 2004

A signed original of this written statement required by Section 906 has been provided to Ventiv Health, Inc. and will be retained by Ventiv Health, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.